China tests new successful Alzheimer's disease

▴ Alzheimer's disease
At last a cure for Alzheimer's disease on the horizon

China's  on much hyped drug on Alzheimer's disease has hit the market raising hopes of millions in China and abroad.Extracted from brown algae this is touted to be first drug for treating brain disorders.Named  availability from as GV-971 China domestic market saw the drug available from Sunday onwards.

Alzheimers disease which afflicts only the elderly destroys all brain function over period of time and there are 50 million patients worldwide.Right now it is priced as $5,700 for yearly quota for a patient which is seen as detterent to it's usage.

Shanghai Green Valley Pharmaceuticals makers of the drug announced they will invest 3 billion for further research including clilical research to better the present drug.

The international trials may take time till 2024 after which it would be availbale globally.

Tags : #newalzheimersdrug #china #launch #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024